Role of human papillomavirus and its detection in potentially malignant and malignant head and neck lesions: Updated review

Head and Neck Oncology

Volumn 1, Issue 1, 2009, Pages

  Chaudhary, Ajay Kumar ^a   Singh, Mamta ^b   Sundaram, Shanthy ^a   Mehrotra, Ravi ^b  

^a UNIVERSITY OF ALLAHABAD   (India)

^b MLN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

BENIGN TUMOR; CANCER RISK; CYTOLOGY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DNA MICROARRAY; GENE EXPRESSION; HEAD AND NECK CANCER; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; HYBRID CAPTURE II; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFECTION PREVENTION; LOW RISK PATIENT; MOLECULAR PATHOLOGY; NONHUMAN; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SOUTHERN BLOTTING; UTERINE CERVIX CARCINOMA; VIRUS IDENTIFICATION; WART VIRUS; GENE EXPRESSION PROFILING; HEAD AND NECK TUMOR; IMMUNOLOGY; ISOLATION AND PURIFICATION; PAPILLOMA VIRUS; PATHOLOGY; VIROLOGY;

GENE EXPRESSION PROFILING; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS VACCINES; POLYMERASE CHAIN REACTION;

EID: 77954372505     PISSN: None     EISSN: 17583284     Source Type: Journal    
DOI: 10.1186/1758-3284-1-22     Document Type: Review

References (107)

1. Flohr JK, Lee JH: Identical but different: mechanism of cancer development and response to treatment for human papillo-mavirus-related and non-related squamous cell cancer of the head and neck. S D Med 2008, 61(12):453-455.
2. American Cancer Society Inc 2008 [http://www.cancer.org/doc-root/STT/content/STT-1x-Cancer-Facts-and-Figures-2008.asp].
3. Mehrotra R, Pandya S, Chaudhary AK, Kumar M, Singh M: Prevalence of oral pre-malignant and malignant lesions at a tertiary level hospital in Allahabad, India. Asian Pac J Cancer Prev 2008, 9(2):263-5.
4. Basu R, Mandal S, Ghosh A, Poddar TK: Role of tobacco in the development of head and neck squamous cell carcinoma in an eastern Indian population. Asian Pac J Cancer Prev 2008, 9(3):381-86.
5. Strati K, Pitot HC, Lambert PF: Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model. Proc Natl Acad Sci 2006, 103(38):14152-7.
6. Syrjänen S: Human papillomavirus (HPV) in head and neck cancer. J Clin Virol 2005, 32(1):59-66.
7. Scully C, Field JK, Tanzawa H: Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol 2000, 36:256-263.
8. Pande P, Soni S, Kaur J, Agarwal S, Mathur M, Shukla NK, Ralhan R: Prognostic factors in betel and tobacco related oral cancer. Oral Oncol 2002, 38:491-499.
9. Girja KP, Sundharam BS, Krishnan PA, Devi CS: Biochemical changes of saliva in tobacco chewers tobacco smokers, alcohol consumers, leukoplakia and oral cancer patients. Indian J Dent Res 2002, 13:102-107.
10. Vidal L, Gillison ML: Human papillomavirus in HNSCC: recognition of a distinct disease type. Hematol Oncol Clin North Am 2008, 22(6):1125-42.
11. Bosh FX, Lorincz A, Munoz N, et al.: The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002, 55:244-265.
12. Funk GF, Karnell LH, Robinson RA, Zhen WK, Trask DK, Hoffman HT: Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report. Head Neck 2002, 24:165-180.
13. Syrjanen S: Human papillomavirus infections and oral tumors. Med Microbiol Immunol 2003, 192:123-128.
14. Campisi G, Giovannelli L: Controversies surrounding Human Papilloma Virus infection, head & neck vs oral cancer, implications for prophylaxis and treatment. Head & Neck Oncology 2009, 1:8.
15. Smith EM, Ritchie JM, Yankowitz J, Wang D, Turek LP, Haugen TH: HPV prevalence and concordance in the cervix and oral cavity of pregnant women. Infect Dis Obstet Gynecol 2004, 12:45-56.
16. Giraldo P, Goncalves AKS, Pereira SA, Barros-Mazon S, Gondo ML, Witkin SS: Human papillomavirus in the oral mucosa of women with genital human papillomavirus lesions. Eur J Obstet Gynecol Reprod Biol 2006, 126:104-106.
17. Syrjänen K, Syrjänen S, Lamberg M, Pyrhönen S, Nuutinen J: Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg 1983, 12(6):418-24.
18. Zur Hausen H: Papillomavirus and cancer: from basic studies to clinical application. Nat Rev Cancer 2002, 2:342-350.
19. Erdmann J: Recent studies attempt to clarify relationship between oral cancer and human papillomavirus. J Natl Cancer Inst 2003, 95:638-639.
20. Nair S, Pillai M: Human papillomavirus and disease mechanisms: relevance to oral and cervical cancers. Oral Dis 2005, 11:350-359.
21. Ha PK, Califano JA: The role of human papillomavirus in oral carcinogenesis. Oral Biol Med 2004, 15(4):188-196.
22. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D: Evidence for a causal association between human papillo-mavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000, 92:709-20.
23. Zur HH: Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000, 92:690-698.
24. Zur Hausen H: Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta 1996, 1288:F55-F78.
25. Boyer SN, Wazer DE, Band V: E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res 1996, 56(20):4620-24.
26. Bouda M, Gorgoulis VG, Kastrinakis NG, Giannoudis A, Tsoli E, Dan-assi-Afentaki D: "High risk" HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa. Mod Pathol 2000, 13(6):644-53.
27. Remmerbach TW, Brinckmann UG, Hemprich A, Chekol M, Kuhndel K, Liebert UG: PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP 5/6 primer sets. J Clin Virol 2004, 30:302-308.
28. Ragin CC, Modugno F, Gollin SM: The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus. J Dent Res 2007, 86(2):104-14.
29. Haddad R, Crum C, Chen Z, Krane J, Posner M, Li Y, Burk R: HPV16 transmission between a couple with HPV-related head and neck cancer. Oral Oncol 2008, 44(8):812-5.
30. Herrero R, Castellsague X, Pawlita M: Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003, 95:1772-83.
31. Smith EM, Ritchie JM, Summersgill KF: Age, sexual behavior and human papillomavirus infection in oral cavity and oropha-ryngeal cancers. Int J Cancer 2004, 108:766-72.
32. Braakhuis BJ, Snijders PJ, Keune WJ, Meijer CJ, Ruijter-Schippers HJ, Leemans CR, Brakenhoff RH: Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst 2004, 96(13):978-80.
33. Chen X, Sturgis EM, El-Naggar AK, Wei Q, Li G: Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers. Carcinogenesis 2008, 29(11):2120-5.
34. Chen X, Sturgis EM, Etzel CJ, Wei Q, Li G: p73 G4C14-to-A4T14 polymorphism and risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never smokers and never drinkers. Cancer 2008, 113(12):3307-14.
35. Ji X, Sturgis EM, Zhao C, Etzel CJ, Wei Q, Li G: Association of p73 G4C14-to-A4T14 polymorphism with human papillomavirus type 16 status in squamous cell carcinoma of the head and neck in non-Hispanic whites. Cancer 2009, 115(8):1660-8.
36. Li G, Sturgis EM, Wang LE, Chamberlain RM, Amos CI, Spitz MR, El-Naggar AK, Hong WK, Wei Q: Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck. Carcinogenesis 2004, 25(10):1911-6.
37. Pintos J, Black MJ, Sadeghi N, Ghadirian P, Zeitouni AG, Viscidi RP, Herrero R, Coutlee F, Franco EL: Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada. Oral Oncol 2008, 44:242-250.
38. Psyrri A, DiMaio D: Human papillomavirus in cervical and head-and-neck cancer. Nat Clin Pract Oncol 2008, 5:24-31.
39. Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM: Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer 2001, 92:805-813.
40. de Villiers EM: Human pathogenic papillomavirus types: an update. Curr Top Microbiol Immunol 1994, 186:1-12.
41. Lee WT, Tubbs RR, Teker AM, Scharpf J, Strome M, Wood B, Lorenz RR, Hunt J: Use of in situ hybridization to detect human papillomavirus in head and neck squamous cell carcinoma patients without a history of alcohol or tobacco use. Arch Pathol Lab Med 2008, 132(10):1653-6.
42. Frazer IH, Leonard JH, Schonrock J, Wright RG, Kearsley JH: HPV DNA in oropharyngeal squamous cell cancers: comparison of results from four DNA detection methods. Pathology 1993, 25:138-143.
43. Kay P, Meehan K, Williamson AL: The use of nested polymerase chain reaction and restriction fragment length polymorphism for the detection and typing of mucosal human papillomaviruses in samples containing low copy numbers of viral DNA. J Virol Methods 2002, 105:159-170.
44. Yeudall WA, Campo MS: Human papillomavirus DNA in biopsies of oral tissues. J Gen Virol 1991, 72:173-176.
45. Tavares R, Passos M, Cavalcanti S, Pinheiro V, Rubinstein I: Condiloma genital em homens e soropositividade para HIV. DST J Bras 2000, 12(1):4-27.
46. Snijders PJ, Meijer CJ, Walboomers JM: Degenerate primers based on highly conserved regions of amino acid sequence in papillomaviruses can be used in a generalized polymerase chain reaction to detect productive human papillomavirus infection. J Gen Virol. 1991, 72(Pt 11):2781-2786.
47. Tieben LM, ter Schegget J, Minnaar RP, Bouwes Bavinck JN, Berkhout RJ, Vermeer BJ: Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J Virol Methods 1993, 42:265-279.
48. Termine N, Panzarella V, Falaschini S, Russo A, Matranga D, Lo Muzio L, Campisi G: HPV in oral squamous cell carcinoma vs. head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). Ann Oncol 2008, 19:1681-1690.
49. Kreimer AR, Clifford GM, Boyle P, Franceschi S: Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005, 14:467-475.
50. Vijver MJ Van de, He YD, van't Veer LJ: A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002, 347:1999-2009.
51. Kuo WP, Jenssen TK, Park PJ, Lingen MW, Hasina R, Ohno-Machado L: Gene expression levels in different stages of progression in oral squamous cell carcinoma. Proc AMIA Symp. 2002:415-419.
52. Guo X, Lui WO, Qian CN: Identifying cancer-related genes in nasopharyngeal carcinoma cell lines uding DNA and mRNA expression profiling analyses. Int J Oncology 2002, 21:1197-1204.
53. Ibrahim SO, Aarsaether N, Holsve MK: Gene expression profile in oral squamous cell carcinomas and matching normal oral mucosal tissues from black Africans and white Caucasians: the case of the Sudan vs. Norway. Oral Oncology 2003, 39:37-48.
54. Martinez I, Wang J, Hobson KF, Ferris RL, Khan SA: Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas. Eur J Cancer 2007, 43(2):415-432.
55. Kovalenko S, Lukashenko P, Romanovskaya A, Soldatski IL, Bakanov SI, Pfister H, Gerein V: Distribution and density of CD1a+ and CD83+ dendritic cells in HPV-associated laryngeal papillomas. Int J Pediatr Otorhinolaryngol 2009, 73(2):249-56.
56. Martins RH, Dias NH, Gregório EA, Marques MA, Silva MG, Candeias JM: Laryngeal papillomatosis: morphological study by light and electron microscopy of the HPV-6. Braz J Otorhinolaryngol 2008, 74(4):539-43.
57. Förster G, Boltze C, Seidel J, Pawlita M, Müller A: Juvenile laryngeal papillomatosis - immunisation with the polyvalent vaccine gardasil. Laryngorhinootologie 2008, 87(11):796-9.
58. DeVoti JA, Rosenthal DW, Wu R, Abramson AL, Steinberg BM, Bonagura VR: Immune dysregulation and tumor-associated gene changes in recurrent respiratory papillomatosis: a paired microarray analysis. Mol Med 2008, 14(9-10):608-17.
59. Castro TP, Bussoloti Filho I: Prevalence of human papillomavirus (HPV) in oral cavity and oropharynx. Braz J Otorhinolaryngol 2006, 72(2):272-82.
60. Fischer M: Investigation of a broad-spectrum PCR assay for human papillomaviruses in screening benign lesions of the upper aerodigestive tract. ORL J Otorhinolaryngol Relat Spec 2005, 67(4):237-41.
61. Hoffmann M, Kahn T, Goeroegh T, Lohrey C, Gottschlich S, Meyer J, Rudert H, Maune S: Tracing human papillomavirus DNA in nasal polyps by polymerase chain reaction. Acta Otolaryngol 2000, 120(7):872-5.
62. Bagan JV, Jimenez Y, Murillo J, Gavaldá C, Poveda R, Scully C, Alberola TM, Torres-Puente M, Pérez-Alonso M: Lack of association between proliferative verrucous leukoplakia and human papillomavirus infection. J Oral Maxillofac Surg 2007, 65(1):46-9.
63. Furrer VE, Benitez MB, Furnes M, Lanfranchi HE, Modesti NM: Biopsy vs. superficial scraping: detection of human papillo-mavirus 6, 11, 16, and 18 in potentially malignant and malignant oral lesions. J Oral Pathol Med 2006, 35(6):338-44.
64. Ostwald C, Rutsatz K, Schweder J, Schmidt W, Gundlach K, Barten M: Human papillomavirus 6/11, 16 and 18 in oral carcinomas and benign oral lesions. Med Microbiol Immunol 2003, 192(3):145-8.
65. Campisi G, Giovannelli L, Aricò P, Lama A, Di Liberto C, Ammatuna P, D'Angelo M: HPV DNA in clinically different variants of oral leukoplakia and lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004, 98(6):705-11.
66. Luo CW, Roan CH, Liu CJ: Human papilloma viruses in oral squamous cell carcinoma and pre-cancerous lesions detected by PCR-based gene-chip array. Int J Oral Maxillofac Surg 2007, 36(2):153-38.
67. Chen PC, Pan CC, Kuo CC, Lin CP: Risk of oral nonmalignant lesion associated with human papillomavirus infection, betel quid chewing, and cigarette smoking in Taiwan: An integrated molecular and epidemiological study. Arch Pathol Lab Med 2006, 130(1):57-61.
68. Vidal A, Júnior A, Mello R, Brandão V, Rocha G, Taromaru E: HPV detection in oral carcinomas. J Bras Patol Med Lab 2004, 40:21-26.
69. Koppikar P, De Villiiers FM, Mulherkar R: Identification of Human papilloma viruses in tumour of the oral cancer in an Indian Community. Int J Cancer 2005, 113:946-50.
70. D'Costa J, Saranath D, Dedhia P, Sanghui V, Mehta AR: Detection of HPV 16 genome in human oral cancer and potentially malignant lesions from India. Oral Oncol 1998, 34(5):413-20.
71. Mishra A, Bharti AC, Varghees P, Saluja D, Das BC: Differential expression of NF-Kappa B family protein during oral carcino - genesis: role of high HPV infection. Int J Cancer 2006, 119:2840-50.
72. König F, Krekeler G, Hönig JF, Cordon-Cardo C, Fischer G, Korabiowska M: Relation between human papillomavirus positivity and p16 expression in head and neck carcinomas - a tissue microarray study. Anticancer Res 2007, 27(1A):283-8.
73. Muenscher A, Feucht HH, Kutta H, Tesche S, Wenzel S: Integration of human papilloma virus type 26 in laryngeal cancer of a child. Auris Nasus Larynx 2009, 36(2):232-4.
74. Morshed K, Polz-Dacewicz M, Szymañski M, Polz D: Short-fragment PCR assay for highly sensitive broad-spectrum detection of human papillomaviruses in laryngeal squamous cell carcinoma and normal mucosa: clinico-pathological evaluation. Eur Arch Otorhinolaryngol 2008, 265(1):89-96.
75. Von Winterfeld F, Fischer M: Broad-spectrum PCR assay for detection of human papillomaviruses in oropharyngeal cancer. Laryngorhinootologie 2007, 86(7):515-9.
76. Torrente MC, Ampuero S, Abud M, Ojeda JM: Molecular detection and typing of human papillomavirus in laryngeal carcinoma specimens. Acta Otolaryngol 2005, 125(8):888-93.
77. Montaldo C, Mastinu A, Quartuccio M, Piras V, Denotti G, Pisano E, Orrù G: Detection and genotyping of human papillomavirus DNA in samples from healthy Sardinian patients: a preliminary study. J Oral Pathol Med 2007, 36(8):482-7.
78. Agrawal Y, Koch WM, Xiao W, Westra WH, Trivett AL, Symer DE, Gillison ML: Oral human papillomavirus infection before and after treatment for human papillomavirus 16-positive and human papillomavirus 16-negative head and neck squamous cell carcinoma. Clin Cancer Res 2008, 14(21):7143-50.
79. Giorgi Rossi P, Ronco G, Segnan N, Borgia P: Screening and vaccine: toward an integrated cervical cancer prevention programme. Epidemiol Prev 2008, 32(4-5):238-43.
80. Marra F, Cloutier K, Oteng B, Marra C, Ogilvie G: Effectiveness and cost effectiveness of human papillomavirus vaccine: a systematic review. Pharmacoeconomics 2009, 27(2):127-47.
81. Tegnell A, Dillner J, Andrae B: Introduction of human papilloma-virus (HPV) vaccination in Sweden. Euro Surveill 2009, 14(6):191-19.
82. Adams M, Jasani B, Fiander A: Prophylactic HPV vaccination for women over 18 years of age. Vaccine 2009, 27(26):3391-4.
83. Brotherton JM, Gold MS, Kemp AS, McIntyre PB, Burgess MA, Campbell-Lloyd S, New South Wales Health HPV Adverse Events Panel: Anaphylaxis following quadrivalent human papillomavirus vaccination. CMAJ. 2008, 79(6):525-533.
84. Lawrence G, Gold MS, Hill R, Deeks S, Glasswell A, McIntyre PB: Annual report: surveillance of adverse events following immunization in Australia, 2007. Commun Dis Intell 2008, 32(4):371-87.
85. Fazekas KI, Brewer NT, Smith JS: HPV vaccine acceptability in a rural Southern area. J Womens Health (Larchmt) 2008, 17(4):539-48.
86. Goncalves MA, Randi G, Arslan A, Villa LL, Burattini MN, Franceschi S, Donadi EA, Massad E: HPV type infection in different ano-genital sites among HIV-positive Brazilian women. Infect Agent Cancer 2008, 3(1):5.
87. Zeuss MS, Miller CS, White DK: In situ hybridization analysis of human papillomavirus DNA in oral mucosal lesions. Oral Surg Oral Med Oral Pathol 1991, 71:714-720.
88. Holladay EB, Gerald WL: Viral gene detection in oral neoplasms using the polymerase chain reaction. Am J Clin Pathol 1993, 100:36-40.
89. Fouret P, Martin F, Flahault A, Saint-Guily JL: Human papillomavirus infection in the malignant and premalignant head and neck epithelium. Diagn Mol Pathol 1995, 4:122-127.
90. Nielsen H, Norrild B, Vedtofte P, Praetorius F, Reibel J, Holmstrup P: Human papillomavirus in oral premalignant lesions. Eur J Cancer B Oral Oncol 1996, 32(B):264-270.
91. Wen S, Tsuji T, Li X, Mizugaki Y, Hayatsu Y, Shinozaki F: Detection and analysis of human papillomavirus 16 and 18 homologous DNA sequences in oral lesions. Anticancer Res 1997, 17:307-311.
92. Lo Muzio L, Campisi G, Giovannelli L, Ammatuna P, Greco I, Staibano S, Pannone G, De Rosa G, Di Liberto C, D'Angelo M: HPV DNA and survivin expression in epithelial oral carcinogenesis: a relationship? Oral Oncol 2004, 40(7):736-41.
93. Giovannelli L, Campisi G, Colella G, Capra G, Di Liberto C, Caleca MP, Matranga D, D'Angelo M, Lo Muzio L, Ammatuna P: Brushing of oral mucosa for diagnosis of HPV infection in patients with potentially malignant and malignant oral lesions. Mol Diagn Ther 2006, 10(1):49-55.
94. Ostwald C, Muller P, Barten M, Rutsatz K, Sonnenburg M, Milde-Langosch K: Human papillomavirus DNA in oral squamous cell carcinomas and normal mucosa. J Oral Pathol Med 1994, 23:220-225.
95. Balaram P, Nalinakumari KR, Abraham E, Balan A, Hareendran NK, Bernard HU: Human papillomaviruses in 91 oral cancers from Indian betel quid chewers - high prevalence and multiplicity of infections. Int J Cancer 1995, 61:450-4.
96. Cruz IB, Snijders PJ, Steenbergen RD, Meijer CJ, Snow GB, Walboomers JM: Age-dependence of human papillomavirus DNA presence in oral squamous cell carcinomas. Eur J Cancer B Oral Oncol. 1996, 32B(1):55-62.
97. Wilczynski SP, Lin BT, Xie Y, Paz IB: Detection of human papillo-mavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma. Am J Pathol 1998, 152:145-156.
98. Bustos J, Gómez B: Characteristics of a macrophage culture persistently infected with herpes simplex virus type 1. Arch Med Res 1999, 30(3):255-62.
99. Van Houten VM, Snijders PJ, Brekel MW van den: Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer 2001, 93(2):232-5.
100. Kojima A, Maeda H, Sugita Y, Tanaka S, Kameyama Y: Human papillomavirus type 38 infection in oral squamous cell carcinomas. Oral Oncol 2002, 38(6):591-6.
101. Sugiyama M, Bhawal UK, Dohmen T, Ono S, Miyauchi M, Ishikawa T: Detection of human papillomavirus-16 and HPV-18 DNA in normal, dysplastic, and malignant oral epithelium. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003, 95(5):594-600.
102. Slebos RJ, Yi Y, Ely K, Carter J, Evjen A, Zhang X, et al.: Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res 2006, 12(31):701-9.
103. Zhang MQ, El-Mofty SK, Dávila RM: Detection of human papillo-mavirus-related squamous cell carcinoma cytologically and by in situ hybridization in fine-needle aspiration biopsies of cervical metastasis: a tool for identifying the site of an occult head and neck primary. Cancer 2008, 114(2):118-23.
104. Chuang AY, Chuang TC, Chang S, Zhou S, Begum S: Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma. Oral Oncol 2008, 44(10):915-9.
105. Simonato LE, Garcia JF, Sundefeld ML, Mattar NJ: Detection of HPV in mouth floor squamous cell carcinoma and its correlation with clinicopathologic variables, risk factors and survival. J Oral Pathol Med 2008, 37(10):593-8.
106. Richards KL, Zhang B, Baggerly KA, Colella S, Lang JC, Schuller DE, Krahe R: Genome-wide hypomethylation in head and neck cancer is more pronounced in HPV-negative tumors and is associated with genomic instability. PLoS One. 2009, 4(3):e4941.
107. Gudleviciene Z, Smailyte G, Mickonas A, Pikelis A: Prevalence of human papillomavirus and other risk factors in Lithuanian patients with head and neck cancer. Oncology 2009, 76(3):205-8.